RT Journal Article
SR Electronic
T1 Surveillance-to-Diagnostic Testing Program for Asymptomatic SARS-CoV-2 Infections on a Large, Urban Campus - Georgia Institute of Technology, Fall 2020
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.28.21250700
DO 10.1101/2021.01.28.21250700
A1 Gibson, Greg
A1 Weitz, Joshua S.
A1 Shannon, Michael P.
A1 Holton, Benjamin
A1 Bryksin, Anton
A1 Liu, Brian
A1 Bramblett, Sandra
A1 Williamson, JulieAnne
A1 Farrell, Michael
A1 Ortiz, Alexander
A1 Abdallah, Chaouki T.
A1 García, Andrés J.
YR 2021
UL http://medrxiv.org/content/early/2021/01/31/2021.01.28.21250700.abstract
AB A SARS-CoV-2 testing program combining pooled saliva sample surveillance leading to diagnosis and intervention surveyed over 112,000 samples from 18,029 students, staff and faculty, as part of integrative efforts to mitigate transmission at the Georgia Institute of Technology in Fall 2020. Cumulatively, 1,508 individuals were confirmed diagnostically. The surveillance strategy, including focused intensification of testing given case clusters, was effective in disrupting transmission following rapid case increases upon entry in August 2020, and again in November 2020. Owing to broad adoption by the campus community, the program protected higher risk staff while allowing some normalization of research activities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding was provided by the Office of the President of the Georgia Institute of TechnologyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Georgia Tech IRB and Office of Legal CounselAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo individual data is available since this was a surveillance study. Summary data can be downloaded from https://health.gatech.edu/coronavirus/health-alerts https://health.gatech.edu/coronavirus/health-alerts